Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities    
Net loss $ (3,612,013) $ (1,636,836)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 384,620 1,236,783
Amortization of license fees 2,940
Amortization of discount of notes payable 281,001 369,714
Amortization of debt issuance costs 76,320 76,984
Amortization of customer acquisition costs 68,934 220,816
Amortization of EERCF patents 100,602 33,534
Depreciation expense 227,968 366,817
Loss on debt exchange 44,036
Settlement Expenses 61,100
Change in assets and liabilities    
Decrease (Increase) in accounts receivable 2,099,273 (655,318)
Decrease (Increase) in inventory 162,867 (299,985)
Decrease in prepaid expenses and other assets 45,889 3,337
(Decrease) in accounts payable and accrued liabilities (251,374) (2,227,879)
(Decrease) in deferred revenue and customer credits (517,060)
Net cash used in operating activities (888,937) (2,447,993)
Cash flows used in investing activities    
Purchase of property and equipment (131,915) (586,429)
Purchase of intellectual property (2,500,000)
Net cash used in investing activities (131,915) (3,086,429)
Cash flows from financing activities    
Payments of promissory notes (875,000) (500,000)
Payment of equipment notes payable (28,594) (26,434)
Net cash used in financing activities (903,594) (526,434)
Net decrease in cash and cash equivalents (1,924,446) (6,060,856)
Cash and cash equivalents - beginning of period 2,418,427 7,751,557
Cash and cash equivalents - end of period 493,981 1,690,701
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid during the period for: Interest 505,431 681,687
SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS    
Equipment purchases included in accounts payable 101,304
Stock issued for interest on convertible notes payable 25,618
Stock issued for the acquisition of patents rights 518,000
Stock issued for settlement $ 61,100